174 related articles for article (PubMed ID: 17140788)
1. A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ.
van Gestel YR; Voogd AC; Vingerhoets AJ; Mols F; Nieuwenhuijzen GA; van Driel OJ; van Berlo CL; van de Poll-Franse LV
Eur J Cancer; 2007 Feb; 43(3):549-56. PubMed ID: 17140788
[TBL] [Abstract][Full Text] [Related]
2. Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer.
Lauzier S; Maunsell E; Levesque P; Mondor M; Robert J; Robidoux A; Provencher L
Breast Cancer Res Treat; 2010 Apr; 120(3):685-91. PubMed ID: 19653097
[TBL] [Abstract][Full Text] [Related]
3. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
4. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
5. Perceptions of contralateral breast cancer: an overestimation of risk.
Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T
Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590
[TBL] [Abstract][Full Text] [Related]
6. Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.
Mazouni C; Peintinger F; Wan-Kau S; Andre F; Gonzalez-Angulo AM; Symmans WF; Meric-Bernstam F; Valero V; Hortobagyi GN; Pusztai L
J Clin Oncol; 2007 Jul; 25(19):2650-5. PubMed ID: 17602071
[TBL] [Abstract][Full Text] [Related]
7. Paget's disease of the nipple in a population based cohort.
Dalberg K; Hellborg H; Wärnberg F
Breast Cancer Res Treat; 2008 Sep; 111(2):313-9. PubMed ID: 17952590
[TBL] [Abstract][Full Text] [Related]
8. Prospective changes in quality of life after ductal carcinoma-in-situ: results from the Nurses' Health Study.
Nekhlyudov L; Kroenke CH; Jung I; Holmes MD; Colditz GA
J Clin Oncol; 2006 Jun; 24(18):2822-7. PubMed ID: 16782920
[TBL] [Abstract][Full Text] [Related]
9. Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast.
Romero L; Klein L; Ye W; Holmes D; Soni R; Silberman H; Lagios MD; Silverstein MJ
Am J Surg; 2004 Oct; 188(4):371-6. PubMed ID: 15474428
[TBL] [Abstract][Full Text] [Related]
10. Does ductal carcinoma in situ accompanying invasive carcinoma affect prognosis?
Chagpar AB; McMasters KM; Sahoo S; Edwards MJ
Surgery; 2009 Oct; 146(4):561-7; discussion 567-8. PubMed ID: 19789013
[TBL] [Abstract][Full Text] [Related]
11. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast.
Schmid BC; Rudas M; Fabjani G; Speiser P; Kaserer K; Leodolter S; Zeillinger R
Oncol Rep; 2003; 10(6):1981-5. PubMed ID: 14534730
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life and psychosocial status in breast cancer prognosis: analysis of multiple variables.
Goodwin PJ; Ennis M; Bordeleau LJ; Pritchard KI; Trudeau ME; Koo J; Hood N
J Clin Oncol; 2004 Oct; 22(20):4184-92. PubMed ID: 15483029
[TBL] [Abstract][Full Text] [Related]
14. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal alterations associated with the transition from in situ to invasive breast cancer.
Ellsworth RE; Vertrees A; Love B; Hooke JA; Ellsworth DL; Shriver CD
Ann Surg Oncol; 2008 Sep; 15(9):2519-25. PubMed ID: 18622645
[TBL] [Abstract][Full Text] [Related]
16. Mapping the quality of life and unmet needs of urban women with metastatic breast cancer.
Aranda S; Schofield P; Weih L; Yates P; Milne D; Faulkner R; Voudouris N
Eur J Cancer Care (Engl); 2005 Jul; 14(3):211-22. PubMed ID: 15952965
[TBL] [Abstract][Full Text] [Related]
17. Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer.
Gold HT; Do HT; Dick AW
Cancer; 2008 Dec; 113(11):3108-15. PubMed ID: 18932243
[TBL] [Abstract][Full Text] [Related]
18. Predictors of surgical margin status in breast-conserving surgery within a breast screening program.
Kurniawan ED; Wong MH; Windle I; Rose A; Mou A; Buchanan M; Collins JP; Miller JA; Gruen RL; Mann GB
Ann Surg Oncol; 2008 Sep; 15(9):2542-9. PubMed ID: 18618180
[TBL] [Abstract][Full Text] [Related]
19. A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer.
Rakovitch E; Franssen E; Kim J; Ackerman I; Pignol JP; Paszat L; Pritchard KI; Ho C; Redelmeier DA
Breast Cancer Res Treat; 2003 Feb; 77(3):285-93. PubMed ID: 12602928
[TBL] [Abstract][Full Text] [Related]
20. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma.
Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S
Breast J; 2008; 14(1):55-60. PubMed ID: 18186866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
